e-learning
resources
Amsterdam 2011
Sunday, 25.09.2011
Anti-inflammatory strategies in acute lung injury
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Intravenous immunoglobulin in community acquired pneumonia
U. Farkhutdinov, A. Mirchaidarov, S. Farkhutdinov (Ufa, Russian Federation)
Source:
Annual Congress 2011 - Anti-inflammatory strategies in acute lung injury
Session:
Anti-inflammatory strategies in acute lung injury
Session type:
Thematic Poster Session
Number:
818
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
U. Farkhutdinov, A. Mirchaidarov, S. Farkhutdinov (Ufa, Russian Federation). Intravenous immunoglobulin in community acquired pneumonia. Eur Respir J 2011; 38: Suppl. 55, 818
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Related content which might interest you:
The effect of intravenous immunoglobulin on active oxygen forms production in patients with community acquired pneumonia
Source: Annual Congress 2010 - New insights into reactive oxygen species
Year: 2010
The effect of intravenous immunoglobulin on oxygen-dependent metabolism of blood cells in patients with community acquired pneumonia
Source: Annual Congress 2012 - Lung injury and repair: reactive oxygen species and beyond
Year: 2012
Effectiveness of the empirical administration of antibiotics in community acquired pneumonia (CAP)
Source: Annual Congress 2007 - Antibiotic treatment in community-acquired pneumonia
Year: 2007
Initial intravenous antibiotic regimen in patients hospitalized for community acquired pneumonia (CAP) in France
Source: Eur Respir J 2003; 22: Suppl. 45, 151s
Year: 2003
Efficacy of intravenous immunoglobulin therapy on the incidence of pneumonia in Iranian patients with common variable immunodeficiency
Source: Eur Respir J 2004; 24: Suppl. 48, 357s
Year: 2004
Usefulness of urinary pneumococcal antigen testing in patients with community acquired pneumonia
Source: Annual Congress 2009 - Aetiology and diagnosis of lower respiratory tract infections
Year: 2009
Severe mixed community acquired pneumonia
Source: Annual Congress 2010 - Aetiology of lower respiratory tract infections and treatment in special situations
Year: 2010
Management of community acquired pneumonia
Source: Annual Congress 2008 - Lower respiratory tract infection: from outbreak to prognostic tests
Year: 2008
Management of community acquired pneumonia
Source: Annual Congress 2010 - Aetiology of lower respiratory tract infections and treatment in special situations
Year: 2010
Intravenous steroids in the treatment of community-acquired pneumonia (CAP)
Source: Eur Respir J 2004; 24: Suppl. 48, 50s
Year: 2004
Corticosteroids and community-acquired pneumonia
Source: Annual Congress 2007 - Corticosteroids and respiratory failure
Year: 2007
Switch from intravenous to oral antibiotic therapy in hospitalized patients with non-severe community acquired pneumonia
Source: Annual Congress 2010 - New aspects of treatment of lower respiratory tract infections
Year: 2010
Treatment with intravenous immunoglobulin (IVG) in children with humoral immune deficiencies and recurrent respiratory tract infections
Source: Eur Respir J 2001; 18: Suppl. 33, 511s
Year: 2001
Impact of determination of urine pneumococcal antigen in the diagnosis of community acquired pneumonia
Source: Annual Congress 2008 - Diagnostic tests in lower respiratory tract infections
Year: 2008
Hyponatraemia in community acquired pneumonia (CAP) in childhood
Source: Eur Respir J 2003; 22: Suppl. 45, 318s
Year: 2003
Using roncoleukine in basic therapy of patients with community acquired pneumonia
Source: Eur Respir J 2002; 20: Suppl. 38, 443s
Year: 2002
Community acquired pneumonia
Source: ERS Skills Course 2017 - Summer school of adult respiratory medicine
Year: 2017
Healthcare-associated pneumonia among hospitalized patients. Is it really different from community acquired pneumonia?
Source: Annual Congress 2012 - Epidemiology: risk factors and prognosis in respiratory infections
Year: 2012
Management of severe community acquired pneumonia
Source: Virtual Congress 2020 – German programme 2020
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept